Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Soliman

Showing results (381-390 of 826) with videos related to

Pageof 83
Sort By:
Journal of Molecular Modeling|October 12, 2022
Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinibGhazi Elamin, Aimen Aljoundi, Mohamed Issa Alahmdi, et al.
International Journal of Molecular Sciences|January 8, 2025
<i>Helichrysum populifolium</i> Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea InfectionVhangani E Mulaudzi, Idowu J Adeosun, Adeniyi T Adewumi, et al.
The American Surgeon|November 23, 2022
A Single-Institution Comparison of Robot-Assisted and Conventional Laparoscopic Colorectal SurgeriesJustin S Roskam, Sara S Soliman, Grace C Chang, et al.
Breast Cancer Research and Treatment|June 11, 2013
Adherence to screening mammography among American Indian women of the Northern PlainsEmily L Roen, Marilyn A Roubidoux, Annette I Joe, et al.
Future Medicinal Chemistry|October 2, 2018
Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocolShama Khan, Imane Bjij, Fisayo A Olotu, et al.
Chemistry & Biodiversity|February 9, 2020
Lipid-Embedded Molecular Dynamics Simulation Model for Exploring the Reverse Prostaglandin D2 Agonism of CT-133 towards CRTH2 in the Treatment of Type-2 Inflammation Dependent DiseasesAbdul Rashid Issahaku, Clement Agoni, Ransford O Kumi, et al.
Journal of Cellular Biochemistry|May 15, 2024
PCSK9 inhibitors as safer therapeutics for atherosclerotic cardiovascular disease (ASCVD): Pharmacophore design and molecular dynamics analysisIbrahim O Kehinde, Oluwole Akawa, Adeniyi T Adewumi, et al.
Cancer Epidemiology|November 22, 2015
Measuring the effect of improvement in methodological techniques on data collection in the Gharbiah population-based cancer registry in Egypt: Implications for other Low- and Middle-Income CountriesBrittney L Smith, Mohamed Ramadan, Brittany Corley, et al.
Journal of Advanced Research|February 17, 2015
Synthesis, characterization and RHF/ab initio simulations of 2-amino-1,3,4-thiadiazole and its annulated ring junction pyrimidine derivativesWafaa S Hamama, Moustafa A Gouda, Mamdouh S Soliman, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 8, 2023
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated <i>BTK</i><sup>Cys481</sup> Waldenström Macroglobulinemia: A Computational ApproachGhazi Elamin, Aimen Aljoundi, Mohamed I Alahmdi, et al.
Pageof 83

Showing results (381-390 of 826) with videos related to

Sort By:
Pageof 83
Journal of Molecular Modeling|October 12, 2022
Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinibGhazi Elamin, Aimen Aljoundi, Mohamed Issa Alahmdi, et al.
International Journal of Molecular Sciences|January 8, 2025
<i>Helichrysum populifolium</i> Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea InfectionVhangani E Mulaudzi, Idowu J Adeosun, Adeniyi T Adewumi, et al.
The American Surgeon|November 23, 2022
A Single-Institution Comparison of Robot-Assisted and Conventional Laparoscopic Colorectal SurgeriesJustin S Roskam, Sara S Soliman, Grace C Chang, et al.
Breast Cancer Research and Treatment|June 11, 2013
Adherence to screening mammography among American Indian women of the Northern PlainsEmily L Roen, Marilyn A Roubidoux, Annette I Joe, et al.
Future Medicinal Chemistry|October 2, 2018
Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocolShama Khan, Imane Bjij, Fisayo A Olotu, et al.
Chemistry & Biodiversity|February 9, 2020
Lipid-Embedded Molecular Dynamics Simulation Model for Exploring the Reverse Prostaglandin D2 Agonism of CT-133 towards CRTH2 in the Treatment of Type-2 Inflammation Dependent DiseasesAbdul Rashid Issahaku, Clement Agoni, Ransford O Kumi, et al.
Journal of Cellular Biochemistry|May 15, 2024
PCSK9 inhibitors as safer therapeutics for atherosclerotic cardiovascular disease (ASCVD): Pharmacophore design and molecular dynamics analysisIbrahim O Kehinde, Oluwole Akawa, Adeniyi T Adewumi, et al.
Cancer Epidemiology|November 22, 2015
Measuring the effect of improvement in methodological techniques on data collection in the Gharbiah population-based cancer registry in Egypt: Implications for other Low- and Middle-Income CountriesBrittney L Smith, Mohamed Ramadan, Brittany Corley, et al.
Journal of Advanced Research|February 17, 2015
Synthesis, characterization and RHF/ab initio simulations of 2-amino-1,3,4-thiadiazole and its annulated ring junction pyrimidine derivativesWafaa S Hamama, Moustafa A Gouda, Mamdouh S Soliman, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 8, 2023
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated <i>BTK</i><sup>Cys481</sup> Waldenström Macroglobulinemia: A Computational ApproachGhazi Elamin, Aimen Aljoundi, Mohamed I Alahmdi, et al.
Pageof 83